Skip to main content
. 2021 Oct 8;10(20):e020519. doi: 10.1161/JAHA.120.020519

Table 1.

Patient Demographics and Preoperative, Intraoperative, and Postoperative Parameters for the Entire Cohort According to Exposure to Preoperative Diuretics

Variable All patients Preoperative diuretic use No preoperative diuretic use P value
n 300 157 143 0.420
Sex, n (% male) 158 (53) 81 (52) 77 (54) 0.696
Age, mo, mean (95% CI) 5.98 (5.7–6.2) 5.4 (5.1–5.7) 6.7 (6.2–7.1) <0.001
Weight, kg, mean (95% CI) 5.8 (5.7–6) 5.2 (5.1–5.4) 6.4 (6.2–6.7) <0.001
Diagnosis, n (%)
TOF 60 (20) 3 57 <0.001
AVSD 42 (14) 33 9 <0.001
Ventricular septal defect 137 (45.7) 102 35 <0.001
Double outlet right ventricle 21 (7) 8 13 0.286
TOF/multiple aortopulmonary collateral arteries 5 (1.7) 1 4 0.208
Total anomalous pulmonary venous return 12 (4) 4 8 0.266
TOF/AVSD 3 (1) 0 3 N/A
Other 20 (6.7) 6 14 0.072
Preoperative parameters
Risk adjustment for surgery for congenital heart surgery
1 1 (0.3) 0 1 N/A
2 202 (67.3) 105 97 0.575
3 89 (29.7) 49 40 0.343
4 8 (2.7) 3 5 0.517
Aristotle score, mean (95% CI) 8 (1.9) 7.7 (7.4–8) 8.3 (8–8.6) 0.007
Intraoperative parameters
Cardiopulmonary bypass time, min, mean (95% CI) 90.2 (85.2–95.2) 81.2 (75.1–87.3) 100.4 (92.4–108.4) <0.001
Cross‐clamp time, min, mean (95% CI) 53.3 (50–56.6) 50.5 (45.8–55.2) 56.5 (51.7–61.3) 0.085
Hypotension, n (%) 62 (21) 35 27 0.449
Vasoactive agent use, n (%) 52 (17) 26 26 0.711
Postoperative parameters
Ventilation (invasive/noninvasive), n (%) 71 (24) 30 41 0.052
Vasoactive agent use, n (%) 126 (42) 52 74 0.001
Junctional rhythm, n (%) 49 (16) 27 22 0.671
Heart block, n (%) 17 (5.7) 7 10 0.343
Cardiac arrest, n (%) 4 (1.3) 0 4 0.050
Extracorporeal life support, n (%) 4 (1.3) 1 3 0.351
Mortality, n (%) 3 (1) 1 2 0.607
Cardiac intensive care unit admission duration, d, mean, (95% CI) 2.8 (1.8–3.8) 2.2 (1.7–2.7) 3.5 (1.5–5.5) 0.190
Hospital admission duration, d, mean, (95% CI) 5.8 (4.8–6.8) 5 (4.5–5.5) 6.7 (4.6–8.8) 0.109

Results from univariate analysis are shown. Vasoactive agents include any of epinephrine, dopamine, and/or milrinone. AVSD indicates atrioventricular septal defect; and TOF, tetralogy of Fallot.